Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program
Olivia M Dong(University of North Carolina at Chapel Hill), Deepak Voora(Duke University), Jason L. Vassy(Boston Medical Center), Craig Heise(University of Arizona), Michael J. Kelley(Durham VA Health Care System), Salvador Rivas(Phoenix VA Health Care System), Jill Bates(University of North Carolina at Chapel Hill), Michael Icardi(University of Iowa), Michael Naglich(Durham VA Medical Center), Peruvemba Sriram(Birmingham VA Medical Center), Maria Ângela Gonçalves de Oliveira Ribeiro(Emory University), Laurence J. Meyer(University of Utah), Jennifer Chapman(Durham VA Medical Center), Russell Jacobitz(North Florida/South Georgia Veterans Health System), Catherine Chanfreau‐Coffinier, Susan Rozelle(North Florida/South Georgia Veterans Health System)
Cited by 33
Related Papers
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
|Nature Genetics|1994|850
Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis.
|Journal of Clinical Investigation|1990|269
Metoprolol for the Prevention of Acute Exacerbations of COPD
|New England Journal of Medicine|2019|177